Skip to main content
. 2021 Feb 24;11:544339. doi: 10.3389/fonc.2021.544339

Table 2.

Tumor responses.

Responses All patients (n = 46) (n or %)
CR 1 (2.2)
PR 6 (13.0)
SD 12 (26.1)
PD 27 (58.7)
ORR 15.2% (95 CI, 4.7–25.7%)
DCR 43.5% (95% CI, 29.0–58.0%)

CR, complete response; DCR, disease control rate; ORR, objective response rate; PD, progressive disease; PR, partial response; SD stable disease.